Literature DB >> 6185431

Interferon potentiation occurs at a pretranscriptive stage.

L A Schwarz, W R Fleischmann.   

Abstract

Combination of interferon-gamma (IFN-gamma) with a mixture of IFN-alpha and IFN-beta (IFN-alpha/beta) produce a potentiated antiviral state. The onset of induction of the potentiated antiviral state was observed to be more rapid than the onset of induction of either IFN-gamma or IFN-alpha/beta separately. The onset of viral resistance to combined IFN-gamma and IFN-alpha/beta (25 U/ml each) began after 2 h, compared with 4 h for IFN-alpha/beta (25 U/ml) alone and 8 h for IFN-gamma (25 U/ml) alone. By adding actinomycin D at various times after interferon treatment, this more rapid onset of induction of the potentiated antiviral state was shown to be the result of a more rapid onset of cellular transcription. To determine whether increased concentrations of IFN-alpha/beta acted through a similar mechanism, we performed kinetic experiments with several concentrations of IFN-alpha/beta and with combined preparations of IFN-gamma and IFN-alpha/beta. The findings showed that treatment of cells with the combined interferons and with a high concentration of IFN-alpha/beta resulted in more rapid onset of cellular transcription and more rapid development of the antiviral state. Thus, the cellular response to potentiation appeared to involve perception by the cell of the combined interferons as a higher-than-expected effective concentration of interferon, resulting in more rapid onset of cellular transcription of mRNA for antiviral proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185431      PMCID: PMC347919          DOI: 10.1128/iai.39.1.159-163.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Unexpectedly rapid action of human interferon in physiological conditions.

Authors:  F Dianzani; S Baron
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

2.  Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.

Authors:  W R Fleischmann; J A Georgiades; L C Osborne; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Effect of interferon on virus production from isolated single cells.

Authors:  W R Fleischmann; E H Simon
Journal:  J Gen Virol       Date:  1973-08       Impact factor: 3.891

4.  Effect of cycloheximide on the antiviral action of interferon.

Authors:  F Dianzani; C E Buckler; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

5.  Immune interferon activates cells more slowly than does virus-induced interferon.

Authors:  F Dianzani; L Salter; W R Fleischmann; M Zucca
Journal:  Proc Soc Exp Biol Med       Date:  1978-10

6.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  General considerations of the interferon system.

Authors:  S Baron; F Dianzani
Journal:  Tex Rep Biol Med       Date:  1977

8.  Purification of mouse L cell interferon. Essentially pure preparations with associated cell growth inhibitory activity.

Authors:  Y Iwakura; S Yonehara; Y Kawade
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

9.  Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.

Authors:  W R Fleischmann; K M Kleyn; S Baron
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

10.  Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.

Authors:  H Ankel; C Krishnamurti; F Besançon; S Stefanos; E Falcoff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  1 in total

Review 1.  Tumor necrosis factor and interferon: cytokines in harmony.

Authors:  Eric Bartee; Mohamed R Mohamed; Grant McFadden
Journal:  Curr Opin Microbiol       Date:  2008-07-01       Impact factor: 7.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.